These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15343359)

  • 1. Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
    Wang XY; Martiniello-Wilks R; Shaw JM; Ho T; Coulston N; Cooke-Yarborough C; Molloy PL; Cameron F; Moghaddam M; Lockett TJ; Webster LK; Smith IK; Both GW; Russell PJ
    Gene Ther; 2004 Nov; 11(21):1559-67. PubMed ID: 15343359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.
    Voeks D; Martiniello-Wilks R; Madden V; Smith K; Bennetts E; Both GW; Russell PJ
    Gene Ther; 2002 Jun; 9(12):759-68. PubMed ID: 12040457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
    Martiniello-Wilks R; Wang XY; Voeks DJ; Dane A; Shaw JM; Mortensen E; Both GW; Russell PJ
    J Gene Med; 2004 Dec; 6(12):1343-57. PubMed ID: 15493036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.
    Martiniello-Wilks R; Dane A; Voeks DJ; Jeyakumar G; Mortensen E; Shaw JM; Wang XY; Both GW; Russell PJ
    J Gene Med; 2004 Jan; 6(1):43-54. PubMed ID: 14716676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.
    Sorscher EJ; Hong JS; Allan PW; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):321-9. PubMed ID: 22760227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors.
    Martiniello-Wilks R; Garcia-Aragon J; Daja MM; Russell P; Both GW; Molloy PL; Lockett LJ; Russell PJ
    Hum Gene Ther; 1998 Jul; 9(11):1617-26. PubMed ID: 9694160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.
    Xie X; Guo J; Kong Y; Xie GX; Li L; Lv N; Xiao X; Tang J; Wang X; Liu P; Yang M; Xie Z; Wei W; Spencer DM; Xie X
    J Gene Med; 2011 Dec; 13(12):680-91. PubMed ID: 22009763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.
    Parker WB; King SA; Allan PW; Bennett LL; Secrist JA; Montgomery JA; Gilbert KS; Waud WR; Wells AH; Gillespie GY; Sorscher EJ
    Hum Gene Ther; 1997 Sep; 8(14):1637-44. PubMed ID: 9322865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.
    Hong JS; Waud WR; Levasseur DN; Townes TM; Wen H; McPherson SA; Moore BA; Bebok Z; Allan PW; Secrist JA; Parker WB; Sorscher EJ
    Cancer Res; 2004 Sep; 64(18):6610-5. PubMed ID: 15374975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription-targeted gene therapy for androgen-independent prostate cancer.
    Martiniello-Wilks R; Tsatralis T; Russell P; Brookes DE; Zandvliet D; Lockett LJ; Both GW; Molloy PL; Russell PJ
    Cancer Gene Ther; 2002 May; 9(5):443-52. PubMed ID: 11961667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Waud WR; Hong JS; Sorscher EJ
    Cancer Gene Ther; 2011 Jun; 18(6):390-8. PubMed ID: 21394111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Hassan AE; Secrist JA; Sorscher EJ; Waud WR
    Cancer Gene Ther; 2003 Jan; 10(1):23-9. PubMed ID: 12489025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
    Tai CK; Wang W; Lai YH; Logg CR; Parker WB; Li YF; Hong JS; Sorscher EJ; Chen TC; Kasahara N
    Cancer Gene Ther; 2010 Sep; 17(9):614-23. PubMed ID: 20467451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy.
    Bharara S; Sorscher EJ; Gillespie GY; Lindsey JR; Hong JS; Curlee KV; Allan PW; Gadi VK; Alexander SA; Secrist JA; Parker WB; Waud WR
    Hum Gene Ther; 2005 Mar; 16(3):339-47. PubMed ID: 15812229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells.
    Messina M; Yu DM; Both GW; Molloy PL; Robinson BG
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1310-8. PubMed ID: 12629124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer.
    Singh PP; Joshi S; Russell PJ; Verma ND; Wang X; Khatri A
    Clin Cancer Res; 2011 Jun; 17(12):4006-18. PubMed ID: 21531822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
    Gadi VK; Alexander SD; Kudlow JE; Allan P; Parker WB; Sorscher EJ
    Gene Ther; 2000 Oct; 7(20):1738-43. PubMed ID: 11083495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA; Abou-Elkhair RAI; Parker WB; Allan PW; Secrist JA
    Eur J Med Chem; 2016 Jan; 108():616-622. PubMed ID: 26724729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy.
    Puhlmann M; Gnant M; Brown CK; Alexander HR; Bartlett DL
    Hum Gene Ther; 1999 Mar; 10(4):649-57. PubMed ID: 10094208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.